 | • レポートコード：MRC2-11QY11436 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は大腸がんのグローバル市場について調査・分析したレポートです。種類別（肉眼検査、顕微鏡検査、免疫化学、病期分類、腫瘍発芽）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別大腸がんの競争状況、市場シェア ・世界の大腸がん市場：種類別市場規模 2015年-2020年（肉眼検査、顕微鏡検査、免疫化学、病期分類、腫瘍発芽） ・世界の大腸がん市場：種類別市場規模予測 2021年-2026年（肉眼検査、顕微鏡検査、免疫化学、病期分類、腫瘍発芽） ・世界の大腸がん市場：用途別市場規模 2015年-2020年（病院・クリニック、その他） ・世界の大腸がん市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他） ・北米の大腸がん市場分析：米国、カナダ ・ヨーロッパの大腸がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの大腸がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の大腸がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの大腸がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Debiopharm、Merck Kgaa、Vaccinogen、Aeterna Zentaris、Keryx、Spectrum Pharmaceuticals、Mologen、Amgen、Bayer Healthcare ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).
The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of weight, nausea, vomiting, fatigue, lump in back passage, and iron deficiency in aged person.
Market Analysis and Insights: Global Colorectal Cancer Market
The global Colorectal Cancer market size is projected to reach US$ 8345 million by 2026, from US$ 8150.1 million in 2020, at a CAGR of 2.2%% during 2021-2026.
Global Colorectal Cancer Scope and Market Size
Colorectal Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Debiopharm
Merck Kgaa
Vaccinogen
Aeterna Zentaris
Keryx
Spectrum Pharmaceuticals
Mologen
Amgen
Bayer Healthcare
Market segment by Type, the product can be split into
Macroscopy
Microscopy
Immunochemistry
Staging
Tumor Budding
Market segment by Application, split into
Hospitals and Clicnics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Colorectal Cancer Revenue
1.4 Market by Type
1.4.1 Global Colorectal Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Macroscopy
1.4.3 Microscopy
1.4.4 Immunochemistry
1.4.5 Staging
1.4.6 Tumor Budding
1.5 Market by Application
1.5.1 Global Colorectal Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clicnics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Market Perspective (2015-2026)
2.2 Global Colorectal Cancer Growth Trends by Regions
2.2.1 Colorectal Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Colorectal Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Colorectal Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Colorectal Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Colorectal Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Players by Market Size
3.1.1 Global Top Colorectal Cancer Players by Revenue (2015-2020)
3.1.2 Global Colorectal Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Colorectal Cancer Market Concentration Ratio
3.2.1 Global Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Revenue in 2019
3.3 Colorectal Cancer Key Players Head office and Area Served
3.4 Key Players Colorectal Cancer Product Solution and Service
3.5 Date of Enter into Colorectal Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Colorectal Cancer Historic Market Size by Type (2015-2020)
4.2 Global Colorectal Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Colorectal Cancer Market Size by Application (2015-2020)
5.2 Global Colorectal Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Colorectal Cancer Market Size (2015-2020)
6.2 Colorectal Cancer Key Players in North America (2019-2020)
6.3 North America Colorectal Cancer Market Size by Type (2015-2020)
6.4 North America Colorectal Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Colorectal Cancer Market Size (2015-2020)
7.2 Colorectal Cancer Key Players in Europe (2019-2020)
7.3 Europe Colorectal Cancer Market Size by Type (2015-2020)
7.4 Europe Colorectal Cancer Market Size by Application (2015-2020)
8 China
8.1 China Colorectal Cancer Market Size (2015-2020)
8.2 Colorectal Cancer Key Players in China (2019-2020)
8.3 China Colorectal Cancer Market Size by Type (2015-2020)
8.4 China Colorectal Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Colorectal Cancer Market Size (2015-2020)
9.2 Colorectal Cancer Key Players in Japan (2019-2020)
9.3 Japan Colorectal Cancer Market Size by Type (2015-2020)
9.4 Japan Colorectal Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Colorectal Cancer Market Size (2015-2020)
10.2 Colorectal Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Colorectal Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Colorectal Cancer Market Size by Application (2015-2020)
11 India
11.1 India Colorectal Cancer Market Size (2015-2020)
11.2 Colorectal Cancer Key Players in India (2019-2020)
11.3 India Colorectal Cancer Market Size by Type (2015-2020)
11.4 India Colorectal Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Colorectal Cancer Market Size (2015-2020)
12.2 Colorectal Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Colorectal Cancer Market Size by Type (2015-2020)
12.4 Central & South America Colorectal Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Colorectal Cancer Introduction
13.1.4 Roche Revenue in Colorectal Cancer Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Debiopharm
13.2.1 Debiopharm Company Details
13.2.2 Debiopharm Business Overview
13.2.3 Debiopharm Colorectal Cancer Introduction
13.2.4 Debiopharm Revenue in Colorectal Cancer Business (2015-2020)
13.2.5 Debiopharm Recent Development
13.3 Merck Kgaa
13.3.1 Merck Kgaa Company Details
13.3.2 Merck Kgaa Business Overview
13.3.3 Merck Kgaa Colorectal Cancer Introduction
13.3.4 Merck Kgaa Revenue in Colorectal Cancer Business (2015-2020)
13.3.5 Merck Kgaa Recent Development
13.4 Vaccinogen
13.4.1 Vaccinogen Company Details
13.4.2 Vaccinogen Business Overview
13.4.3 Vaccinogen Colorectal Cancer Introduction
13.4.4 Vaccinogen Revenue in Colorectal Cancer Business (2015-2020)
13.4.5 Vaccinogen Recent Development
13.5 Aeterna Zentaris
13.5.1 Aeterna Zentaris Company Details
13.5.2 Aeterna Zentaris Business Overview
13.5.3 Aeterna Zentaris Colorectal Cancer Introduction
13.5.4 Aeterna Zentaris Revenue in Colorectal Cancer Business (2015-2020)
13.5.5 Aeterna Zentaris Recent Development
13.6 Keryx
13.6.1 Keryx Company Details
13.6.2 Keryx Business Overview
13.6.3 Keryx Colorectal Cancer Introduction
13.6.4 Keryx Revenue in Colorectal Cancer Business (2015-2020)
13.6.5 Keryx Recent Development
13.7 Spectrum Pharmaceuticals
13.7.1 Spectrum Pharmaceuticals Company Details
13.7.2 Spectrum Pharmaceuticals Business Overview
13.7.3 Spectrum Pharmaceuticals Colorectal Cancer Introduction
13.7.4 Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2015-2020)
13.7.5 Spectrum Pharmaceuticals Recent Development
13.8 Mologen
13.8.1 Mologen Company Details
13.8.2 Mologen Business Overview
13.8.3 Mologen Colorectal Cancer Introduction
13.8.4 Mologen Revenue in Colorectal Cancer Business (2015-2020)
13.8.5 Mologen Recent Development
13.9 Amgen
13.9.1 Amgen Company Details
13.9.2 Amgen Business Overview
13.9.3 Amgen Colorectal Cancer Introduction
13.9.4 Amgen Revenue in Colorectal Cancer Business (2015-2020)
13.9.5 Amgen Recent Development
13.10 Bayer Healthcare
13.10.1 Bayer Healthcare Company Details
13.10.2 Bayer Healthcare Business Overview
13.10.3 Bayer Healthcare Colorectal Cancer Introduction
13.10.4 Bayer Healthcare Revenue in Colorectal Cancer Business (2015-2020)
13.10.5 Bayer Healthcare Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Colorectal Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Colorectal Cancer Revenue
Table 3. Ranking of Global Top Colorectal Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Colorectal Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Macroscopy
Table 6. Key Players of Microscopy
Table 7. Key Players of Immunochemistry
Table 8. Key Players of Staging
Table 9. Key Players of Tumor Budding
Table 10. Global Colorectal Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Colorectal Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Colorectal Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Colorectal Cancer Market Share by Regions (2015-2020)
Table 14. Global Colorectal Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Colorectal Cancer Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Colorectal Cancer Market Growth Strategy
Table 20. Main Points Interviewed from Key Colorectal Cancer Players
Table 21. Global Colorectal Cancer Revenue by Players (2015-2020) (Million US$)
Table 22. Global Colorectal Cancer Market Share by Players (2015-2020)
Table 23. Global Top Colorectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer as of 2019)
Table 24. Global Colorectal Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Colorectal Cancer Product Solution and Service
Table 27. Date of Enter into Colorectal Cancer Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 30. Global Colorectal Cancer Market Size Share by Type (2015-2020)
Table 31. Global Colorectal Cancer Revenue Market Share by Type (2021-2026)
Table 32. Global Colorectal Cancer Market Size Share by Application (2015-2020)
Table 33. Global Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 34. Global Colorectal Cancer Market Size Share by Application (2021-2026)
Table 35. North America Key Players Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Colorectal Cancer Market Share (2019-2020)
Table 37. North America Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 38. North America Colorectal Cancer Market Share by Type (2015-2020)
Table 39. North America Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 40. North America Colorectal Cancer Market Share by Application (2015-2020)
Table 41. Europe Key Players Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Colorectal Cancer Market Share (2019-2020)
Table 43. Europe Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Colorectal Cancer Market Share by Type (2015-2020)
Table 45. Europe Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Colorectal Cancer Market Share by Application (2015-2020)
Table 47. China Key Players Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 48. China Key Players Colorectal Cancer Market Share (2019-2020)
Table 49. China Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 50. China Colorectal Cancer Market Share by Type (2015-2020)
Table 51. China Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 52. China Colorectal Cancer Market Share by Application (2015-2020)
Table 53. Japan Key Players Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Colorectal Cancer Market Share (2019-2020)
Table 55. Japan Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Colorectal Cancer Market Share by Type (2015-2020)
Table 57. Japan Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Colorectal Cancer Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Colorectal Cancer Market Share (2019-2020)
Table 61. Southeast Asia Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Colorectal Cancer Market Share by Type (2015-2020)
Table 63. Southeast Asia Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Colorectal Cancer Market Share by Application (2015-2020)
Table 65. India Key Players Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 66. India Key Players Colorectal Cancer Market Share (2019-2020)
Table 67. India Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 68. India Colorectal Cancer Market Share by Type (2015-2020)
Table 69. India Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 70. India Colorectal Cancer Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Colorectal Cancer Market Share (2019-2020)
Table 73. Central & South America Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Colorectal Cancer Market Share by Type (2015-2020)
Table 75. Central & South America Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Colorectal Cancer Market Share by Application (2015-2020)
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Product
Table 80. Roche Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 81. Roche Recent Development
Table 82. Debiopharm Company Details
Table 83. Debiopharm Business Overview
Table 84. Debiopharm Product
Table 85. Debiopharm Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 86. Debiopharm Recent Development
Table 87. Merck Kgaa Company Details
Table 88. Merck Kgaa Business Overview
Table 89. Merck Kgaa Product
Table 90. Merck Kgaa Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 91. Merck Kgaa Recent Development
Table 92. Vaccinogen Company Details
Table 93. Vaccinogen Business Overview
Table 94. Vaccinogen Product
Table 95. Vaccinogen Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 96. Vaccinogen Recent Development
Table 97. Aeterna Zentaris Company Details
Table 98. Aeterna Zentaris Business Overview
Table 99. Aeterna Zentaris Product
Table 100. Aeterna Zentaris Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 101. Aeterna Zentaris Recent Development
Table 102. Keryx Company Details
Table 103. Keryx Business Overview
Table 104. Keryx Product
Table 105. Keryx Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 106. Keryx Recent Development
Table 107. Spectrum Pharmaceuticals Company Details
Table 108. Spectrum Pharmaceuticals Business Overview
Table 109. Spectrum Pharmaceuticals Product
Table 110. Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 111. Spectrum Pharmaceuticals Recent Development
Table 112. Mologen Business Overview
Table 113. Mologen Product
Table 114. Mologen Company Details
Table 115. Mologen Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 116. Mologen Recent Development
Table 117. Amgen Company Details
Table 118. Amgen Business Overview
Table 119. Amgen Product
Table 120. Amgen Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 121. Amgen Recent Development
Table 122. Bayer Healthcare Company Details
Table 123. Bayer Healthcare Business Overview
Table 124. Bayer Healthcare Product
Table 125. Bayer Healthcare Revenue in Colorectal Cancer Business (2015-2020) (Million US$)
Table 126. Bayer Healthcare Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Market Share by Type: 2020 VS 2026
Figure 2. Macroscopy Features
Figure 3. Microscopy Features
Figure 4. Immunochemistry Features
Figure 5. Staging Features
Figure 6. Tumor Budding Features
Figure 7. Global Colorectal Cancer Market Share by Application: 2020 VS 2026
Figure 8. Hospitals and Clicnics Case Studies
Figure 9. Others Case Studies
Figure 10. Colorectal Cancer Report Years Considered
Figure 11. Global Colorectal Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Colorectal Cancer Market Share by Regions: 2020 VS 2026
Figure 13. Global Colorectal Cancer Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Colorectal Cancer Market Share by Players in 2019
Figure 16. Global Top Colorectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Colorectal Cancer Revenue in 2019
Figure 18. North America Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…- 大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…
- 大腸がん診断の世界市場（～2026年） Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness alon…
- 肛門癌・結腸直腸癌の世界市場（～2026年） Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in anus in case of anal cancer. Rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has been the major factor driving the market …
- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…